Documentos relacionados

1. Pathogenicity and landscape of differential gene expression in mice orally infected with clinical coxsackievirus A6 (CA6).
2. Production of antigenically stable enterovirus A71 virus-like particles in <i>Pichia pastoris</i> as a vaccine candidate.
3. <i>Clostridia</i> and Enteroviruses as Synergistic Triggers of Type 1 Diabetes Mellitus.
4. Efficacy, safety, and immunogenicity of an inactivated, adjuvanted enterovirus 71 vaccine in infants and children: a multiregion, double-blind, randomised, placebo-controlled, phase 3 trial.
5. Seroprevalence of coxsackievirus A6 and enterovirus A71 infection in humans: a systematic review and meta-analysis.
6. Antibody signatures in hospitalized hand, foot and mouth disease patients with acute enterovirus A71 infection.
7. Seroprevalence of Enterovirus D68 Infection among Humans: A Systematic Review and Meta-Analysis.
8. Enterovirus virus-like-particle and inactivated poliovirus vaccines do not elicit substantive cross-reactive antibody responses.
9. Assessment of Enterovirus Antibodies during Early Childhood Using a Multiplex Immunoassay.
10. Does enterovirus 71 urge for effective vaccine control strategies? Challenges and current opinion.